Research Articles
Achieving Reproducibility in Organoid Research: A Comprehensive Guide to Standardized Culture Protocols
Organoid technology has revolutionized biomedical research by providing physiologically relevant in vitro models.
Genomic Predictors of Drug Sensitivity in Cancer: A Comparative Analysis of Models, Validation & Clinical Translation
This article provides a comprehensive comparative analysis of computational models for predicting anticancer drug sensitivity from genomic data.
Umbrella vs Basket Trials in Oncology: A Comprehensive Guide to Master Protocol Designs
This article provides a detailed comparison of umbrella and basket trial designs, two innovative master protocol frameworks revolutionizing oncology drug development.
Optimizing DNA Extraction from Liquid Biopsy: A Comprehensive Guide for Robust cfDNA Recovery and Analysis
This article provides a comprehensive guide for researchers and drug development professionals on optimizing DNA extraction from liquid biopsy samples.
Overcoming Drug Resistance in Targeted Therapies: Mechanisms, Strategies, and Future Directions
This comprehensive review addresses the pervasive challenge of drug resistance in molecularly targeted therapies, a critical barrier in oncology and beyond.
Bridging the Translational Gap: Strategies for Optimizing Preclinical Models in Drug Development
This article addresses the critical challenge of translating promising preclinical findings into clinical success, a persistent bottleneck in drug development.
Next-Generation Biomarkers and AI: Strategies for Enhancing Sensitivity and Specificity in Early Disease Detection
This article synthesizes the latest methodologies and validation frameworks for improving the sensitivity and specificity of early detection tests, with a focus on cancer and other diseases.
Managing Immune-Related Adverse Events in Cancer Immunotherapy: From Mechanisms to Clinical Practice and Future Directions
This comprehensive review addresses the critical challenge of immune-related adverse events (irAEs) associated with cancer immunotherapy, particularly immune checkpoint inhibitors.
Beyond the Biopsy: Addressing Key Limitations in Cancer Diagnostics and Forging a Path to Precision Oncology
This article provides a comprehensive analysis of the current limitations in cancer diagnostics, exploring the foundational biological, technological, and systemic barriers that hinder accurate and timely detection.
Beyond PD-L1: Advancing Predictive Biomarkers for Immunotherapy Response in Oncology
Immunotherapy has revolutionized cancer treatment, yet patient response rates remain variable, underscoring the critical need for robust predictive biomarkers.